An open-label study of the safety and efficacy of sertaconazole nitrate in the treatment of seborrheic dermatitis.

Author: CantrellWendy C, ElewskiBoni E

Paper Details 
Original Abstract of the Article :
OBJECTIVES: To demonstrate the efficacy and evaluate the safety of sertaconazole nitrate cream 2% in the treatment of seborrheic dermatitis (SD). DESIGN: Single-center, open-label study. SETTING: One academic medical center. PARTICIPANTS: Twenty adult male and female subjects aged 22 to 85 years ...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://pubmed.ncbi.nlm.nih.gov/21818511

データ提供:米国国立医学図書館(NLM)

A Study on the Safety and Efficacy of Sertaconazole Nitrate in Treating Seborrheic Dermatitis

This study, a single-center, open-label investigation in the realm of dermatology, aimed to evaluate the effectiveness and safety of sertaconazole nitrate cream 2% in managing seborrheic dermatitis (SD). The researchers examined 20 adults (aged 22 to 85 years) with mild to severe facial SD. The primary endpoint was the proportion of subjects achieving a score of 0 or 1 on the Investigator's Static Global Assessment scale at the end of treatment (week 4). Secondary endpoints included changes in erythema, scaling, induration, and pruritus at a preselected target lesion, along with alterations in scores on the Subject's Global Assessment scale and the Dermatology Life Quality Index.

Positive Results for Treating Seborrheic Dermatitis

The findings revealed that 10 out of 17 evaluable subjects (58.8%) achieved success based on the primary endpoint. Significant improvements were observed in the Investigator's Static Global Assessment score from baseline at each week of treatment. Furthermore, remarkable improvements were also demonstrated in erythema, scaling, induration, and pruritus at week 4 compared to baseline. Changes in Subject's Global Assessment scores compared to baseline were statistically significant only at week 1 (P=0.031). The total mean SD Dermatology Life Quality Index scores improved from baseline to week 4, with a change of 0.34 (± 0.62, P=0.039).

Hope for Managing Seborrheic Dermatitis

This preliminary study suggests that sertaconazole nitrate cream 2% is a promising treatment option for seborrheic dermatitis, demonstrating both efficacy and safety. It may bring relief to individuals grappling with the uncomfortable symptoms of SD, potentially improving their quality of life.

Dr.Camel's Conclusion

As a seasoned researcher, I can say this research shows promise. While more research is needed, it provides a ray of hope for those suffering from seborrheic dermatitis. It's like finding a cool oasis in the middle of the dry desert, offering a refreshing solution for a persistent problem.

Date :
  1. Date Completed 2012-02-02
  2. Date Revised 2014-07-30
Further Info :

Pubmed ID

21818511

DOI: Digital Object Identifier

21818511

Related Literature

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.